Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-20 | 2023-09 | 0 | N/A | N/A | N/A |
2023-05-10 | 2023-03 | 0 | N/A | N/A | N/A |
2023-04-17 | 2022-12 | 0 | N/A | N/A | N/A |
2022-11-21 | 2022-09 | -4.8 | N/A | N/A | N/A |
2022-11-10 | 2022-06 | 0 | N/A | N/A | N/A |
2022-05-23 | 2022-03 | -7.21 | N/A | N/A | N/A |
Split | Date |
---|---|
1 : 30 | 2023-05-17 |
1 : 10 | 2020-09-08 |
1 : 30 | 2018-07-10 |
1 : 3 | 2016-09-29 |
-
RS is coming soon
-
See you Monday at $1
-
Absolutely holding. No selling
-
See you at $2
-
Wtf.....
-
What is happening
-
Shit If trnx didn’t do a r/s how can Bioc
-
I think we get news Monday not today
-
BIOC. I believe
-
BIOC$ i believe
-
$BIOC man if I had more to buy with my avg .54 just riding it out
-
The article from 2015 is not why it is bullish. They are required to meet NASDAQ listing requirement of $1 and have just released news that they are distributing COVID testing kits a month early across the US. When the official PR drops, it’s going to run; the R/S is most likely NOT happening. Additionally it has very good consolidation going on on the daily. If it doesn’t spike by today or gap up by Monday, congratulations bears, but there’s a very slim chance
-
@ED_RNtrader I see your post about the amazing calls you got, is there a way I could fallow you and a few others to learn from and get nice calls my self I tried searching but can’t find no one
-
1 day green a week or what
-
Cracks me up. It’s still under the last offering
-
And red here we come
-
So EOD movement??
-
Please just get bought out. Management is trash
-
What the actual fuck. It was at .49
-
This stock is my worst nightmare
-
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
businesswire.com • -
Biocept to Participate in the H.C. Wainwright Global Investment Conference
businesswire.com • -
Biocept, Inc. (BIOC) Business Update Conference Call (Transcript)
seekingalpha.com • -
Biocept to Hold Business Update Conference Call on August 30, 2023
businesswire.com • -
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole
investorplace.com • -
Biocept Reports Second Quarter 2023 Financial Results
businesswire.com • -
Biocept CNSide assay takes the spotlight at 2023 SNO/ASCO CNS Cancer Conference
proactiveinvestors.com • -
Biocept Announces the Passing of Board Chair M. Faye Wilson
businesswire.com • -
Biocept appoints Antonino Morales as president and chief executive officer
proactiveinvestors.com • -
Biocept Names Antonino Morales as President and Chief Executive Officer
businesswire.com • -
Why Is Biocept (BIOC) Stock Down 42% Today?
investorplace.com • -
Biocept Announces Pricing of $5.0 Million Underwritten Public Offering
businesswire.com • -
Biocept shares to commence trading on split-adjusted basis
proactiveinvestors.com • -
Biocept Announces One-for-Thirty Reverse Stock Split
businesswire.com • -
Biocept Announces One-for-Thirty Reverse Stock Split
businesswire.com •